Liver Tumors: Assessing Cancer Risk and Follow-Up Care

There is a tumor in the liver?

Hello Doctor: In February, an abdominal ultrasound revealed two tumors in my liver (0.6 cm and 1.7 cm).
During a follow-up in April, another tumor was found (0.8 cm).
The previous two tumors had not grown, and the doctor mentioned that they might have been previously undetected.
I was advised to have another follow-up and blood tests.
The blood test results are as follows: no hepatitis B, GOP: 26, GPT: 37 (previously these were 153 and 382, and the doctor prescribed medication for chronic hepatitis).
Alpha-fetoprotein: 1.96, CA 19-9: 17.9, Carcinoembryonic antigen: 2.70.
There is no family history of hepatitis or liver cancer.
Based on this information, what is my risk of liver cancer?

Miss Lin, 30~39 year old female. Ask Date: 2017/04/14

Dr. Chen Shidian reply Gastroenterology and Hepatology

Hello, the probability is low, but further monitoring is needed.
If necessary, a CT scan or MRI may be performed for evaluation.
Changhua Hospital cares about your health.
Chen Shidian

Reply Date: 2017/04/14

More Info

Understanding liver tumors and assessing cancer risk is a complex process that involves multiple factors, including tumor size, growth patterns, liver function tests, and family history. Based on your situation, where you have been diagnosed with two liver tumors measuring 0.6 cm and 1.7 cm, and a third tumor measuring 0.8 cm, it is essential to consider several aspects to evaluate your risk of liver cancer.

Firstly, the size of the tumors is a critical factor. Generally, tumors smaller than 2 cm are often monitored closely, especially if they are stable in size over time. Your doctor’s observation that the two initial tumors have not grown significantly is a positive sign. Tumors that remain stable or show minimal growth are less likely to be malignant. However, the presence of multiple tumors can complicate the assessment, as it may indicate a higher risk of malignancy, particularly if there are changes in size or new lesions appear.

Your blood test results are also crucial in assessing your risk. The liver function tests (GOP and GPT) you provided indicate a significant improvement from previous values, suggesting that your liver function is stabilizing, especially with the treatment for chronic hepatitis. Normal levels of alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are also reassuring, as elevated levels of these markers can indicate liver cancer or other malignancies. Your AFP level of 1.96 ng/mL is well within the normal range, which is typically below 10 ng/mL, and your CEA level of 2.70 ng/mL is also considered normal.

Family history plays a significant role in cancer risk assessment. Since you mentioned that there is no family history of liver disease or liver cancer, this further reduces your risk profile. However, it is essential to continue monitoring your liver health, as liver cancer can still occur in individuals without a family history, particularly in the presence of chronic liver disease.

In terms of follow-up care, regular monitoring through imaging studies such as ultrasound or CT scans is vital. Your doctor may recommend follow-up scans every 3 to 6 months to track the size and number of tumors. Additionally, continuing blood tests to monitor liver function and tumor markers will help in early detection of any changes that may indicate malignancy.

Lifestyle modifications can also play a significant role in liver health. Maintaining a healthy diet, avoiding alcohol, and managing any underlying conditions such as diabetes or obesity can help reduce the risk of liver cancer. Regular exercise and weight management are also beneficial for overall liver health.

In conclusion, while the presence of liver tumors can be concerning, your current situation, characterized by stable tumor sizes, improving liver function tests, and normal tumor markers, suggests a lower risk of liver cancer at this time. However, continued vigilance through regular follow-ups and lifestyle modifications is essential. Always consult with your healthcare provider for personalized advice and to discuss any changes in your condition or concerns you may have.

Similar Q&A

Understanding Liver Cancer Diagnosis: Key Insights and Follow-Up Care

Hello Doctor: I have been a carrier of hepatitis B since childhood. During a health check-up, it was found that my liver GOT and GPT levels were elevated. I went to a gastroenterology clinic for blood tests and discovered that my AFP level was 166, which was also elevated. The do...

Dr. Chen Shidian reply Gastroenterology and Hepatology
It is recommended to discuss the follow-up plan with the attending physician based on the current examination data.

Understanding Liver Tumors: Causes, Risks, and Treatment Options

Dear Dr. Lin, 1. My father is 70 years old and has recently experienced some health issues. He has over ten tumors in his liver, but the biopsy report indicates that the largest one is necrotic, so the report appears to be fine. However, the doctor mentioned that based on clinic...

Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello: 1. There are instances where tumors may be associated with necrosis, and elevated CA 19-9 levels can indicate various conditions, including malignant ones such as pancreatic cancer, cholangiocarcinoma, and gastrointestinal cancers. Benign conditions may include cholecystit...

Understanding Liver Health: Risks of Cirrhosis and Cancer

Hello Dr. Tsai! I am the patient who consulted you a few days ago regarding my condition. After reviewing my report, do you think I am at risk for liver cirrhosis? Also, would you consider me to be in a high-risk group for liver cancer? Thank you, and I would like to know if you ...

Dr. Cai Anshun reply Gastroenterology and Hepatology
Hello: 1. Currently, the report does not indicate the presence of cirrhosis; whether it will develop in the future will require ongoing monitoring. 2. To determine if you are in a high-risk group for liver cancer, you should consult your clinical physician, who can assess your pr...

Managing Liver Tumor Treatment: Patient Guidance and Medication Options

My father has undergone multiple treatments for liver tumors, including several embolizations and radiofrequency ablations. During a follow-up appointment, his alpha-fetoprotein (AFP) level was still 21.9. When I asked the attending physician, they were unsure of the reason. I wo...

Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello, after multiple treatments for liver cancer, the AFP level remains high. It is recommended to compare the current AFP value with previous values. Common causes of elevated AFP include chronic hepatitis, liver cirrhosis, and liver cancer. Elevated AFP can still occur in case...